Myocardial Infarction in the Elderly: Benefits and Risks of Thrombolytics

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.11, 2002-01, pp. : 753-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombolytics play an important part in the treatment of ST-segment elevation myocardial infarction

Drugs & Therapy Perspectives, Vol. 26, Iss. 9, 2010-09 ,pp. : 10-14

Adis International

Access to resources Recommend Favorite

Optimizing the Use of Thrombolytics in ST-Segment Elevation Myocardial Infarction

By Morse Michael A. Todd Josh W. Stouffer George A.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1945-1966

Adis International

Access to resources Recommend Favorite

Best to get in quick for eptifibatide benefits in myocardial infarction

Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Salbutamol: Myocardial infarction in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1152, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Discontinuation of β-Blockers and the Risk of Myocardial Infarction in the Elderly

By Teichert Martina de Smet Peter A.G.M. Hofman Albert Witteman Jacqueline C.M. Stricker Bruno H.Ch.

Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. : 541-549

Adis International

Access to resources Recommend Favorite